Efficacy News and Research

RSS

Neon Therapeutics evaluates safety, efficacy of NEO-PV-01 in combination with KEYTRUDA and chemotherapy

Neon Therapeutics, a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced that it has treated the first patient in a clinical trial evaluating its proprietary personal neoantigen vaccine, NEO-PV-01, in combination with Merck's anti-PD-1 therapy, KEYTRUDA®, along with chemotherapy.

8 May 2018

Researchers examine whether current health regulations at mines are sufficient to decrease lung diseases

While on-the-job fatalities due to injuries and accidents have steadily decreased in nearly every industry in the U.S., the burden of debilitating lung disease in the coal mining industry has sharply increased within the last decade.

8 May 2018

FDA grants approval for two drugs administered together to treat aggressive form of thyroid cancer

The U.S. Food and Drug Administration approved Tafinlar (dabrafenib) and Mekinist (trametinib), administered together, for the treatment of anaplastic thyroid cancer (ATC) that cannot be removed by surgery or has spread to other parts of the body (metastatic), and has a type of abnormal gene, BRAF V600E (BRAF V600E mutation-positive).

8 May 2018

Tradeshow Talks with Keneric Healthcare

Tradeshow Talks with Keneric Healthcare at Health GB 2018.

7 May 2018

Very low carbohydrate diet may improve blood sugar control in type 1 diabetes

A new study led by researchers at Boston Children’s Hospital has shown that a very-low-carbohydrate diet can improve blood sugar control among people with type 1 diabetes.

7 May 2018

Fujitsu announces development of molecular simulation technology for drug discovery

Fujitsu Laboratories Ltd. and Fujitsu Limited today announced the development of molecular simulation technology for drug discovery that can accurately estimate binding affinity, which represents the degree to which proteins that can cause diseases (target proteins) bind to chemical substances that could become candidate drugs.

7 May 2018

Very-low-carb diets found to improve blood sugar control in type 1 diabetes

ery-low-carbohydrate diets can improve blood sugar control in type 1 diabetes, with low rates of hypoglycemia and other complications, according to an online patient survey.

7 May 2018

Sylentis presents clinical study results of new treatment for dry eye syndrome

Sylentis, Pharmaceutical Company belonging to the PharmaMar Group, has presented results from the clinical studies carried out with tivanisiran for the treatment of dry eye syndrome and that has enabled the start-up of the Phase III "Helix" clinical trial.

3 May 2018

Maternal placentophagy does not cause harm to newborn babies, study finds

The largest study of its kind found mothers who consumed their placenta passed on no harm to their newborn babies when compared to infants of mothers who did not consume their placenta.

3 May 2018

Researchers develop novel theranostic procedure for treating ductal pancreatic adenocarcinoma

German researchers have developed a novel diagnostic and therapeutic (theranostic) procedure for patients with ductal pancreatic adenocarcinoma, a deadly cancer with an extremely poor prognosis (five-year survival rate of less than 5 percent) and limited treatment options. The study is featured in the May issue of The Journal of Nuclear Medicine.

2 May 2018

Study examines effectiveness of MDMA-assisted psychotherapy in service personnel with PTSD

A new experimental study has tested the safety and effectiveness of MDMA-assisted psychotherapy in 26 service personnel with post-traumatic stress disorder (PTSD).

2 May 2018

Study shows safety, efficacy of stem cells in treating angiitis-induced critical limb ischemia

A long-term study of patients who received stem cells to treat angiitis-induced critical limb ischemia (AICLI) shows the cells to be both safe and effective.

2 May 2018

New vaccine strategy increases number of tumor-specific cancer-killing T cells

New research published in Cancer Immunology Research by Drs. Esteban Celis and Hussein Sultan of the Georgia Cancer Center at Augusta University could serve as the stepping-stone in constructing vaccines with a greater likelihood of finding and attacking tumors in the human body.

2 May 2018

New T cell biomarker could be much-needed patient-selection tool for CAR T cell therapy

Penn Medicine researchers may have found the reason why some patients with advanced chronic lymphocytic leukemia don't respond to chimeric antigen receptor T cell therapy, and the answer is tied to how primed patients' immune systems are before the therapy is administered.

30 Apr 2018

BTG presents OPTALYSE PE results at Society for Cardiovascular Angiography and Interventions

BTG plc, the global healthcare company, highlighted the presentation of OPTALYSE PE trial results at the Society for Cardiovascular Angiography and Interventions in San Diego, California.

28 Apr 2018

Results of AVIATOR 2 international registry announced at SCAI 2018 Scientific Sessions

Results of the AVIATOR 2 international registry are being presented as late-breaking clinical science at the Society for Cardiovascular Angiography and Interventions (SCAI) 2018 Scientific Sessions.

28 Apr 2018

University of Pennsylvania expert investigates novel treatment for cocaine addiction

Cocaine and other drugs of abuse hijack the natural reward circuits in the brain. In part, that's why it's so hard to quit using these substances.

28 Apr 2018

New results reinforce COPAXONE 40 mg/mL as safe and effective for RMS patients

Teva Pharmaceutical Industries Ltd., today announced up to 7-year efficacy, safety and tolerability results from the Glatiramer Acetate Low-Frequency Administration (GALA) open-label extension study of COPAXONE (glatiramer acetate injection) 40 mg/mL administered subcutaneously three-times-a-week for the treatment of relapsing forms of multiple sclerosis (RMS).

28 Apr 2018

Pioneering study could be a step closer to finding the most effective way to treat cancer

Doctors could be a step closer to finding the most effective way to treat cancer with a double whammy of a virus combined with boosting the natural immune system, according to a pioneering study by researchers at The University of Texas Health Science Center at Houston (UTHealth) and The Ohio State University.

27 Apr 2018

Study examines efficacy of 3D printing, computer modeling to predict paravalvular leak in TAVR

A new study examines the effectiveness of 3D printing technology and computer modeling to predict paravalvular leak in patients undergoing transcatheter aortic valve replacement (TAVR). A common risk of TAVR is an ill-fitting valve which can lead to PVL.

27 Apr 2018

Efficacy News and Research

Neon Therapeutics evaluates safety, efficacy of NEO-PV-01 in combination with KEYTRUDA and chemotherapy

Researchers examine whether current health regulations at mines are sufficient to decrease lung diseases

FDA grants approval for two drugs administered together to treat aggressive form of thyroid cancer

Tradeshow Talks with Keneric Healthcare

Very low carbohydrate diet may improve blood sugar control in type 1 diabetes

Fujitsu announces development of molecular simulation technology for drug discovery

Very-low-carb diets found to improve blood sugar control in type 1 diabetes

Sylentis presents clinical study results of new treatment for dry eye syndrome

Maternal placentophagy does not cause harm to newborn babies, study finds

Researchers develop novel theranostic procedure for treating ductal pancreatic adenocarcinoma

Study examines effectiveness of MDMA-assisted psychotherapy in service personnel with PTSD

Study shows safety, efficacy of stem cells in treating angiitis-induced critical limb ischemia

New vaccine strategy increases number of tumor-specific cancer-killing T cells

New T cell biomarker could be much-needed patient-selection tool for CAR T cell therapy

BTG presents OPTALYSE PE results at Society for Cardiovascular Angiography and Interventions

Results of AVIATOR 2 international registry announced at SCAI 2018 Scientific Sessions

University of Pennsylvania expert investigates novel treatment for cocaine addiction

New results reinforce COPAXONE 40 mg/mL as safe and effective for RMS patients

Pioneering study could be a step closer to finding the most effective way to treat cancer

Study examines efficacy of 3D printing, computer modeling to predict paravalvular leak in TAVR

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News